Literature DB >> 27003298

Oxidative Stress and DNA Damage in Untreated First-Episode Psychosis in Adolescents.

Şeref Şimşek1, Salih Gençoğlan, Tuğba Yüksel, İbrahim Kaplan, Rümeysa Alaca, Hüseyin Aktaş.   

Abstract

OBJECTIVE: Oxidative stress has been reported to play a role in the psychopathology of schizophrenia, though only a few studies have investigated the relationship between early-onset schizophrenia and oxidative stress. The aim of the present study is to evaluate the level of oxidative stress and the presence of DNA damage in first-episode psychosis (FEP) in adolescents.
METHODS: This study was conducted in the Department of Child Psychiatry of the Dicle University Hospital. It included 20 adolescent patients (age 11-17 years) with psychosis (acute psychosis, schizophreniform disorder, or schizophrenia) according to DSM-IV criteria who had received no previous psychiatric therapy (patient group) and 20 age/gender-matched healthy adolescents (control group). Structured psychiatric interviews [Kiddie Schedule for Affective Disorders and Schizophrenia, Present and Lifetime Version (K-SADS-PL) and Positive and Negative Symptom Scale (PANSS)] were conducted on the patients, and the Clinical Global Impressions (CGI) scale was used to evaluate the severity of disease. Glutathione peroxidase (GPx), superoxide dismutase (SOD), coenzyme Q (CoQ), and 8-hydroxy-2-deoxyguanosine (8-OHdG) levels were determined using the ELISA method and commercial ELISA kits.
RESULTS: The mean age was 14.5 ± 1.6 years in the FEP group (male-to-female ratio: 8/12) and 14.4 ± 1.5 years in the control group (male-to-female ratio: 8/12). There were no differences between the patient and control groups in terms of SOD, GPx, or 8-OHdG values (p > 0.05).
CONCLUSIONS: This study on DNA damage and oxidative stress in FEP in adolescents had a small sample size, and our data suggest that oxidative stress is associated with a chronic disease course rather than being an early sign of early-onset schizophrenia.
© 2016 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27003298     DOI: 10.1159/000444488

Source DB:  PubMed          Journal:  Neuropsychobiology        ISSN: 0302-282X            Impact factor:   2.328


  12 in total

Review 1.  Recent Reports on Redox Stress-Induced Mitochondrial DNA Variations, Neuroglial Interactions, and NMDA Receptor System in Pathophysiology of Schizophrenia.

Authors:  Narasimha M Beeraka; Marco F Avila-Rodriguez; Gjumrakch Aliev
Journal:  Mol Neurobiol       Date:  2022-01-27       Impact factor: 5.590

2.  NADPH-oxidase 4 gene over-expression in peripheral blood lymphocytes of the schizophrenia patients.

Authors:  Elizaveta S Ershova; Galina V Shmarina; Andrey V Martynov; Natalia V Zakharova; Roman V Veiko; Pavel E Umriukhin; George P Kostyuk; Sergey I Kutsev; Natalia N Veiko; Svetlana V Kostyuk
Journal:  PLoS One       Date:  2022-06-13       Impact factor: 3.752

3.  Interrelationships Between BDNF, Superoxide Dismutase, and Cognitive Impairment in Drug-Naive First-Episode Patients With Schizophrenia.

Authors:  Mei Hong Xiu; Zezhi Li; Da Chun Chen; Song Chen; Maile E Curbo; Hanjing Emily Wu; Yong Sheng Tong; Shu Ping Tan; Xiang Yang Zhang
Journal:  Schizophr Bull       Date:  2020-12-01       Impact factor: 9.306

4.  High serum levels of 8-OHdG are an independent predictor of post-stroke depression in Chinese stroke survivors.

Authors:  Zhihua Liu; Yan Cai; Jincai He
Journal:  Neuropsychiatr Dis Treat       Date:  2018-02-19       Impact factor: 2.570

Review 5.  Translational Significance of Selective Estrogen Receptor Modulators in Psychiatric Disorders.

Authors:  Mohammad M Khan
Journal:  Int J Endocrinol       Date:  2018-10-08       Impact factor: 3.257

6.  Determining Pro-Oxidant Antioxidant Balance (PAB) and Total Antioxidant Capacity (TAC) in Patients with Schizophrenia.

Authors:  Farnaz Zahedi Avval; Niloufar Mahmoudi; Abolfazl Nosrati Tirkani; Lida Jarahi; Daryoush Hamidi Alamdari; Seyed Alireza Sadjadi
Journal:  Iran J Psychiatry       Date:  2018-07

7.  Elevated activity of superoxide dismutase in male late-life schizophrenia and its correlation with clinical symptoms and cognitive deficits.

Authors:  Lijuan Huo; Xiaobing Lu; Fengchun Wu; Catherine Chang; Yuping Ning; Xiang Yang Zhang
Journal:  BMC Psychiatry       Date:  2021-12-04       Impact factor: 3.630

8.  Altered Antioxidant Defenses in Drug-Naive First Episode Patients with Schizophrenia Are Associated with Poor Treatment Response to Risperidone: 12-Week Results from a Prospective Longitudinal Study.

Authors:  Xi Rong Li; Mei Hong Xiu; Xiao Ni Guan; Yue Chan Wang; Jun Wang; Edison Leung; Xiang Yang Zhang
Journal:  Neurotherapeutics       Date:  2021-03-31       Impact factor: 7.620

Review 9.  Oxidative Stress and Inflammation in Early Onset First Episode Psychosis: A Systematic Review and Meta-Analysis.

Authors:  David Fraguas; Covadonga M Díaz-Caneja; Alberto Rodríguez-Quiroga; Celso Arango
Journal:  Int J Neuropsychopharmacol       Date:  2017-06-01       Impact factor: 5.176

Review 10.  Inflammation, Stress Response, and Redox Dysregulation Biomarkers: Clinical Outcomes and Pharmacological Implications for Psychosis.

Authors:  Stefania Schiavone; Luigia Trabace
Journal:  Front Psychiatry       Date:  2017-10-25       Impact factor: 4.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.